Action CLBIO CORLINE BIOMEDICAL AB
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Corline Biomedical AB

Actions

CLBIO

SE0006887451

Marché Fermé - Nasdaq Stockholm
Autres places de cotation
 16:58:32 17/05/2024 		Varia. 5j. Varia. 1 janv.
10,5 SEK +3,96% Graphique intraday de Corline Biomedical AB +3,96% -29,53%
30/04 Corline Biomedical AB annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
14/02 Corline Biomedical AB annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Corline Biomedical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2023
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2022
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Corline Biomedical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2022
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Corline Biomedical AB Reports Earnings Results for the Second Quarter Ended June 30, 2021
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2021
Corline Biomedical AB announced that it has received SEK 35.475 million in funding from M2 Asset Management AB, HealthInvest Partners AB, and other investors
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
Corline Biomedical AB to Enter into Agreement with the Clinical Islet Transplant Program at University of Alberta
Corline Biomedical AB to Enter into Agreement with Nuffield Department of Surgical Sciences
Corline Biomedical AB has completed an IPO in the amount of SEK 12.04 million.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action CLBIO
  4. Actualités Corline Biomedical AB
  5. Autres langues